PRKN and Alzheimer disease: As a known E3 ubiquitin ligase, the transient silencing of p53-induced RING-H2 protein (Pirh2) has been shown to reduce levels of pathological markers characteristic of AD, such as hyperphosphorylation of Tau protein and excessive accumulation of Aβ.